TMHC
—
—
Loading…
—
—
MASTER
—
—
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—
📊 ESEN MASTER SCORE ANALYSIS — TMHC
| Metric | Grade | Score | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | D+ | 52 | Negative growth momentum, weak profitability flags, defensive valuation offset by deteriorating fundamentals | 6–12M |
| SA Quality/Value Composite | D | 48 | P/E 8.52× (attractive in isolation), but EPS -22% YoY and revenue -9% YoY signal structural weakness | TTM |
| Zacks Earnings Momentum | F | 28 | EPS YoY: -22.04% | Forward P/E 13.69× (vs. trailing 8.52×) implies negative near-term revisions | 1–3M |
| Institutional & Smart Money Flow | C | 62 | Week52 return +12.66%, price near 52-week high (72.5). Defensive inflows possible; data gaps prevent confirmation | 6–12M |
| Growth Sustainability & Moat | F | 24 | Revenue -8.99% YoY, EPS -22.04% YoY. No hyper-growth, no strong profitability flags. Consumer cyclical exposure in uncertain macro | 6–12M |
| Valuation & Safety (Pre-Penalty) | C+ | 68 | P/E 8.52× is 36% discount vs. forward 13.69×. Low risk of overpayment but earnings revisions risk is high | 6–12M |
| Penalty Overlay (Earnings Risk) | −14 pts | −14 | Negative EPS growth, no dividend support, beta −0.55 (anomalous; defensive tilt), forward P/E expansion signals caution | 1–3M |
| CONFIDENCE SCORE | C | 61 | Data gaps: no earnings date, no dividend data, no analyst targets. Coverage constrained. Metrics sufficient for directional call only | 6–12M |
| Volatility & Drawdown Risk | D+ | 55 | Beta −0.55 (unusual negative beta; suggests structural hedging or data artifact). Week52 range 54.15–72.5 = 33.8% span. Moderate–high drawdown risk in tech or rate shock | 1–3M |
| Crowding Risk Flag | CAUTION | — | 52-week return +12.66% into technical resistance (near 52w high). Week52_low 54.15 = 25% downside break-even. Small cap (market cap 6.67B) may face volume constraints on exits | 1–3M |
🏆 Peer & Sector Context
Taylor Morrison (TMHC) operates in the homebuilder/residential construction sector, a cyclical consumer discretionary segment highly sensitive to interest rates, housing demand, and macro sentiment. With negative EPS and revenue growth YoY, TMHC is underperforming sector recoveries typical of post-2024 normalization. The P/E of 8.52× is historically cheap for the homebuilding peer set (which typically trades 10–14× in expansion), but the forward P/E of 13.69× suggests analyst consensus expects further earnings pressure or margin compression in the near term. Dividend-less structure and negative growth indicate no near-term shareholder distributions; total return is equity-appreciation dependent.
📈 Dual-Horizon Outlook
1–3 Month Horizon (Tactical):
Negative. EPS momentum is sharply negative (−22% YoY), and the forward P/E repricing signals that analyst consensus is cutting earnings estimates. Price at 72.45 is 0.2% below Friday close and holds near 52-week high (72.50), offering limited upside cushion. Risk of a 15–20% pullback to the 200-day MA or technical support if earnings disappointment emerges or macro sentiment deteriorates. Avoid accumulation.
6–12 Month Horizon (Strategic):
Cautious-to-Neutral. Housing cycle dynamics and interest rate trajectory are critical. If Fed cuts sustainably (mortgage rates fall), homebuilder demand could revive, potentially reversing negative YoY trends by Q4 2026 or Q1 2027. A P/E recompression to 10–11× (sector average) on stabilized or recovering earnings could support a 15–20% upside. However, structural headwinds (supply-chain costs, labor inflation, rising construction input) persist. Risk/reward asymmetry is modest. Best case: macro-driven recovery. Base case: continued margin pressure. Worst case: housing slowdown drives P/E to 7× or lower.
💡 Key Metrics Snapshot
Price
$72.45
P/E (Trailing)
8.52×
Forward P/E
13.69×
EPS YoY
−22.04%
Revenue YoY
−8.99%
Market Cap
$6.67B
Week52 High
$72.50
Week52 Return
+12.66%
🎯 FINAL INSTITUTIONAL VERDICT
HOLD / AVOID NEAR-TERM: TMHC trades at attractive backward valuation (P/E 8.5×) but deteriorating fundamentals (−22% EPS YoY, −9% revenue YoY) and negative earnings momentum justify a cautious stance. Near-term downside risk (15–20%) outweighs upside unless housing cycle inflects decisively. Suitable only for deep-value, high-conviction macro bulls betting on Fed pivot and housing recovery in H2 2026. Confidence in forecast limited by data gaps (no earnings dates, no targets). Recommend re-evaluation post-next earnings call or on material macro shifts.
AI STOCK INSIGHT
TMHC Stock Analysis & Forecast
Is TMHC a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
TMHC Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, TMHC shows balanced risk-reward characteristics.
Should You Buy TMHC Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in TMHC.